{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:58:57Z","timestamp":1790351937595,"version":"4.1.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background and aims<\/jats:title><jats:p>Metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to substitute NAFLD in 2020. This new term highlights the systematic metabolic disturbances that accompany fatty liver. We evaluated the correlations between MAFLD and subclinical carotid atherosclerosis (SCA) based on a nationwide health examination population in China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a nationwide cross-sectional population and a Beijing retrospective cohort from 2009 to 2017. SCA was defined as elevated carotid intima-media thickness. The multivariable logistic and Cox models were used to analyze the association between MAFLD and SCA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>153,482 participants were included in the cross-sectional study. MAFLD was significantly associated with SCA in fully adjusted models, with an odds ratio of 1.66; 95% confidence interval (CI): 1.62-1.70. This association was consistent in the cohort, with a hazard ratio (HR) of 1.31. The association between baseline MAFLD and incident SCA increased with hepatic steatosis severity. Subgroup analysis showed an interaction between age and MAFLD, with a higher risk in younger groups (HR:1.67, 95% CI: 1.17-2.40).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this large cross-section and cohort study, MAFLD was significantly associated with the presence and development of SCA. Further, the risk was higher among MAFLD individuals with high hepatic steatosis index and young adults.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1109673","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T05:29:13Z","timestamp":1680586153000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China"],"prefix":"10.3389","volume":"14","author":[{"given":"Fang","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Mao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Juan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Xiao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huo-ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-013003","article-title":"Innate immune signaling in nonalcoholic fatty liver disease and cardiovascular diseases","volume":"14","author":"Cai","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2021.10.007","article-title":"NAFLD as a continuous driver in the whole spectrum of vascular disease","volume":"163","author":"Li","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32072","article-title":"Nonalcoholic fatty liver disease and cardiac remodeling risk: Pathophysiological mechanisms and clinical implications","volume":"74","author":"Zhou","year":"2021","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1161\/CIRCRESAHA.119.316337","article-title":"Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases","volume":"126","author":"Cai","year":"2020","journal-title":"Circ Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: A systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1007171","article-title":"The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China","volume":"13","author":"Lei","year":"2022","journal-title":"Front Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)61139-7","article-title":"Carotid intima-media thickness and coronary artery calcium score as indications of subclinical atherosclerosis","volume":"84","author":"Lester","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.628875","article-title":"Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.10.2498","article-title":"Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: Role of visceral fat accumulation","volume":"27","author":"Targher","year":"2004","journal-title":"Diabetes Care"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2013.07.052","article-title":"A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care","volume":"230","author":"Oni","year":"2013","journal-title":"Atherosclerosis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154779","article-title":"The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis","volume":"120","author":"Liu","year":"2021","journal-title":"Metabolism"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.12.039","article-title":"Trajectories of age-related arterial stiffness in chinese men and women","volume":"75","author":"Lu","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.11.060","article-title":"Co-Occurrence of chronic pain, depressive symptoms, and poor sleep quality in a health check-up population in china:a multicenter survey","volume":"281","author":"Cao","year":"2021","journal-title":"J Affect Disord"},{"key":"B15","volume-title":"White paper on trend insights of china\u2019s comprehensive health management service industry","year":"2021"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3760\/cma.j.cn112138-20211027-00751","article-title":"Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)","volume":"61","year":"2022","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.11909\/j.issn.1671-5411.2019.03.014","article-title":"2018 chinese guidelines for prevention and treatment of hypertension-a report of the revision committee of chinese guidelines for prevention and treatment of hypertension","volume":"16","year":"2019","journal-title":"J Geriatr. Cardiol"},{"key":"B18","first-page":"390","article-title":"Chinese Guidelines on prevention and treatment of dyslipidemia in adults","volume":"35","year":"2007","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5603\/CJ.a2021.0001","article-title":"Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update","volume":"28","author":"Borghi","year":"2021","journal-title":"Cardiol J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006040368","article-title":"Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease","volume":"17","author":"Ma","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"B24","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.10.016","article-title":"Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease","volume":"76","author":"Guo","year":"2022","journal-title":"J Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3760\/cma.j.issn.1007-3418.2018.03.008","article-title":"Guidelines of prevention and treatment for nonalcoholic fatty liver disease: A 2018 update","volume":"26","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2016.06.001","article-title":"Persistent nonalcoholic fatty liver disease increases risk for carotid atherosclerosis","volume":"151","author":"Sinn","year":"2016","journal-title":"Gastroenterology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002847","article-title":"Comparison of imputation methods for missing laboratory data in medicine","volume":"3","author":"Waljee","year":"2013","journal-title":"BMJ Open"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: The difference between two estimates","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: Old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.atherosclerosis.2015.01.001","article-title":"A concise review of non-alcoholic fatty liver disease","volume":"239","author":"Than","year":"2015","journal-title":"Atherosclerosis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2017.68821","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis","volume":"14","author":"Sao","year":"2018","journal-title":"Arch Med Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: Causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.045","article-title":"Hepatic steatosis and cardiovascular disease outcomes: An analysis of the framingham heart study","volume":"63","author":"Mellinger","year":"2015","journal-title":"J Hepatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.04.009","article-title":"Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men","volume":"240","author":"Ozturk","year":"2015","journal-title":"Atherosclerosis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.08.011","article-title":"Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpoints","volume":"144","author":"Buckley","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245762","article-title":"Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study","volume":"16","author":"Niriella","year":"2021","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: A nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-021-01828-6","article-title":"Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: A retrospective nationwide claims database study in Japan","volume":"56","author":"Yoneda","year":"2021","journal-title":"J Gastroenterol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.968766","article-title":"Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269265","article-title":"A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis","volume":"17","author":"Bessho","year":"2022","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10252-0","article-title":"Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: A matched case-control study","volume":"15","author":"Liu","year":"2021","journal-title":"Hepatol Int"},{"key":"B47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12933-022-01697-0","article-title":"Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention","volume":"21","author":"Zhou","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12875-020-01306-7","article-title":"Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: Is there an association","volume":"21","author":"Miptah","year":"2020","journal-title":"BMC Fam. Pract"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.05.002","article-title":"Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease","volume":"241","author":"Chen","year":"2015","journal-title":"Atherosclerosis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14322","article-title":"Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score","volume":"40","author":"Xin","year":"2020","journal-title":"Liver Int"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: When pathophysiology succeeds","volume":"17","author":"Tilg","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17040460","article-title":"NAFLD and increased aortic stiffness: Parallel or common physiopathological mechanisms? int","volume":"17","author":"Villela-Nogueira","year":"2016","journal-title":"J Mol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05299-4","article-title":"Gut bacteria alleviate smoking-related NASH by degrading gut nicotine","volume":"610","author":"Chen","year":"2022","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2174\/138161210792062858","article-title":"Impact of tobacco smoking on lipid metabolism, body weight and cardiometabolic risk","volume":"16","author":"Gastaldelli","year":"2010","journal-title":"Curr Pharm Des"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.08.041","article-title":"NASH and atherosclerosis are two aspects of a shared disease: Central role for macrophages","volume":"220","author":"Bieghs","year":"2012","journal-title":"Atherosclerosis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s10620-011-1819-3","article-title":"The relationship between arterial stiffness and nonalcoholic fatty liver disease","volume":"57","author":"Lee","year":"2012","journal-title":"Dig Dis Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20781","article-title":"Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease","volume":"42","author":"Villanova","year":"2005","journal-title":"Hepatology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i16.1861","article-title":"Macrophages in metabolic associated fatty liver disease","volume":"26","author":"Alharthi","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i10.1325","article-title":"Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis","volume":"7","author":"Polimeni","year":"2015","journal-title":"World J Hepatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.cmet.2020.08.001","article-title":"A membrane-bound diacylglycerol species induces PKC-mediated hepatic insulin resistance","volume":"32","author":"Lyu","year":"2020","journal-title":"Cell Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03760-6","article-title":"Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease","volume":"21","author":"Shao","year":"2023","journal-title":"J Transl Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1109673\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T05:29:22Z","timestamp":1680586162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1109673\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":63,"alternative-id":["10.3389\/fendo.2023.1109673"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1109673","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]},"article-number":"1109673"}}